Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 1/2 4Phase 2 3Phase 1 3Phase EARLY_PHASE1 1

Status

Terminated 2Completed 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 1522Carcinoma, Non-Small-Cell Lung 758Breast Neoplasms 572Neoplasm Metastasis 531Colorectal Neoplasms 448Melanoma 391Leukemia, Myeloid, Acute 372Multiple Myeloma 364Ovarian Neoplasms 354Recurrence 336Lymphoma 334Advanced Solid Tumors 325Lymphoma, Non-Hodgkin 315Prostatic Neoplasms 300Pancreatic Neoplasms 285Advanced Solid Tumor 240Stomach Neoplasms 233Carcinoma, Renal Cell 226Squamous Cell Carcinoma of Head and Neck 211Lung Neoplasms 210Solid Tumor 204Leukemia, Lymphocytic, Chronic, B-Cell 198Triple Negative Breast Neoplasms 185Solid Tumors 183Carcinoma, Hepatocellular 165Hematologic Neoplasms 155Head and Neck Neoplasms 153Lymphoma, Large B-Cell, Diffuse 148Lymphoma, Follicular 146Glioblastoma 145

Interventions

Norepinephrine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × Radiodermatitis × Clear all
NCT01714973 2019-05-13

Study of ST266 Versus Saline in Treating Skin Irritation From Radiation

Noveome Biotherapeutics, formerly Stemnion

Phase 1 Completed
20 enrolled

Radiodermatitis

NCT01263366 2013-04-19

Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients

ProCertus BioPharm, Inc

Phase 1 Terminated
10 enrolled

Radiodermatitis

NCT01367990 2012-03-23

Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy

ProCertus BioPharm, Inc

Phase 1 Terminated
3 enrolled
Head & Neck

Alopecia, Head and Neck Neoplasms, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡